Company Acceleration Request

July 14, 2020


Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549-3720



Ada Sarmento


Christine Torney


Lynn Dicker


Mary Beth Breslin



ALX Oncology Holdings Inc.


Registration Statement on Form S-1


(File No. 333-239490)

Acceleration Request

Requested Date:     Thursday, July 16, 2020

Requested Time:     4:00 P.M. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, ALX Oncology Holdings Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-l (File No. 333-239490) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Michael Coke at (650) 565-3596.

[Signature page follows]




/s/ Jaume Pons

Jaume Pons, Ph.D.

President and Chief Executive Officer



cc (w/o enclosures):

Peter García, ALX Oncology Holdings Inc.


Jason Trimborn, KPMG LLP


Brittany Bockman, KPMG LLP


Dave Peinsipp, Cooley LLP


Kristin VanderPas, Cooley LLP


Michael Coke, Wilson Sonsini Goodrich & Rosati, P.C.


Christina Poulsen, Wilson Sonsini Goodrich & Rosati, P.C.